One goal of the proposed studies will be to evaluate the possibility that resistance to insulin stimulated glucose uptake is a common defect in patients with hypertension. In order to examine this hypothesis we will attempt to confirm the presence of ambient hyperinsulinemia in patients with hypertension, and to use the insulin clamp technique to see if patients with hypertension are insulin resistant. In addition, we will measure plasma lipid and lipoprotein concentrations in patients with hypertension, both non-diabetic and diabetic, in order to examine the possibility that abnormalities of glucose and insulin metabolism are correlated with the abnormalities of lipid metabolism that have been reported to occur in association with hypertension. In this endeavor we will also control for the effects of anti-hypertensive treatment in order to differentiate between the effects of hypertension, per se, or carbohydrate and lipid metabolism, as contrasted to changes due to the treatment of hypertension. Another major objective of the proposed studies will be to assess the effects of variations in the relative proportion of dietary fat and carbohydrates on plasma glucose, insulin, lipid and lipoprotein concentrations in hypertension and non-insulin-dependent diabetes mellitus (NIDDM). Finally, we will evaluate the effects of NIDDM, before and after glycemia control, on measurements of both low density lipoprotein and high density lipoprotein kinetics.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL008506-24
Application #
3334232
Study Section
Metabolism Study Section (MET)
Project Start
1977-01-01
Project End
1992-02-29
Budget Start
1987-03-01
Budget End
1988-02-29
Support Year
24
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Stuhlinger, Markus C; Abbasi, Fahim; Chu, James W et al. (2002) Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287:1420-6